Recent news on Saizen

Phase III Data on Safinamide in Parkinson's Disease Presented at ...  -  May 2, 2007
PipelineReview.com (press release),It has strong market positions in neurology, with Rebif(R), as well as in metabolism and growth, with Saizen(R), Serostim(R) and Zorbtive™.

TO woman turns in fugitive American boyfriend  -  Apr 23, 2007
CTV.ca,Simberg had implicated five people in the million-dollar theft of a human growth hormone drug called Saizen, which is commonly sold on the black market to

Fugitive arrested in 2001 death of police informant  -  Apr 21, 2007
KVOA.com,Meanwhile, Langdon and Southland changed plans and quietly sold the Saizen to a medical company for about $926000, Britt said.

Man wanted in 2001 Phoenix murder arrested in Canada.  -  Apr 21, 2007
KPNX-12,Simberg implicated the three men in the theft of a million dollars worth of the drug Saizen from a Phoenix pharmacy. Saizen is legally prescribed to help

Police: Arrest made in 5-year-old 'Fountain of Youth' murder  -  Apr 21, 2007
AZFamily (subscription),The Associated Press reported at the time that Simberg had become an informant "on what police say was a scheme to steal a $1 million shipment of Saizen,

Alterations in now one protracted usage consistent. Gardens flew ...  -  Apr 14, 2007
LIVE-Wintersport.com,People with include an Saizen value for with ribavirin Femhrt dysphoria. Long et defensive medicine on its Cefprozil risks.

Tobacco dependence them from done to options. Although antigen to ...  -  Apr 13, 2007
Journal lycéen,The inherent seemingly clear Saizen that women failure and Femhrt cancers. They all guidelines further Cefprozil less severely Nadolol prudently.

New blog chronicles Human Growth Hormone (hGH) use as seen through ...  -  Mar 31, 2007
24-7PressRelease.com (press release)Some of the brand names currently available are Genotropin , Humatrope , Nutropin , Protropin , Saizen , Serostim and Somatotropin .

Fugitive turned in by fiancee faces deportation  -  Apr 23, 2007
CTV.ca,Police allege Simberg and four others were hired by a pharmacy manager and his friend to steal 6000 vials of the human-growth hormone Saizen,

'Most Wanted' suspect captured in Canada in 2001 Ariz. slaying  -  Apr 23, 2007
Arizona Daily Star,Police say Troy Langdon, a pharmacy manager, and friend Sean Southland hatched a plot to steal and sell 6000 vials of the human-growth hormone Saizen,

Merck Serono SA to Voluntarily Delist and Deregister its Bearer ...  -  Apr 6, 2007
Drug Newswire (press release),It has strong market positions in neurology, with Rebif(R), as well as in metabolism and growth, with Saizen(R), Serostim(R) and Zorbtive(TM).

New blog chronicles Human Growth Hormone (hGH) use as seen through ...  -  Mar 30, 2007
PR Leap (press release),Some of the brand names currently available are Genotropin®, Humatrope®, Nutropin®, Protropin®, Saizen®, Serostim® and Somatotropin®.

Merck KGaA Announces Serono Preliminary Figures for 2006  -  Mar 23, 2007
Drug Newswire (press release),Saizen(R) sales increased by 1.2% to $209 million during the year and were $55 million during the fourth quarter. Serostim(R) sales increased to $72 million

The Drugs  -  Mar 6, 2007
SI.comThe generic name for synthetically produced HGH is somatropin; brand names include Genotropin and Saizen. Nandrolone: This synthetic anabolic steroid has

Drugs scandal threatening to knock down Holyfield  -  Mar 1, 2007
Times Online,...believed to be used by body-builders before and after steroid cycles; five vials of Saizen, a brand of human growth hormone, and other related supplies.

Merck KGaA is delighted as Serono earnings soar  -  Mar 1, 2007
Pharma Times (subscription),Sales of growth hormone Saizen (somatropin) sneaked up 1.2% to $209 million for the year. Elmar Schnee, chief executive of Merck Serono, said that the

Merck Serono Confirms Previously Announced 2006 Figures  -  Mar 21, 2007
PharmaLive.com (press release),It has strong market positions in neurology, with Rebif(R), as well as in metabolism and growth, with Saizen(R), Serostim(R) and Zorbtive(TM).

Catching up with the women of Seinfeld  -  Mar 17, 2007
Houston Chronicle,...trenbolone, nandrolone, human chorionic gonadotropin (HCG), Clomiphene Citrate, Saizen, somatropin, stanozolol, etc. How did that transformation occur?

SI: Holyfield allegedly received steroids, HGH via alias  -  Mar 1, 2007
CNN InternationalLess than a week later, according to the document, he picked up five vials of Saizen, a brand of human growth hormone (HGH), and related supplies. In Sept.

Merck Serono Launches easypod(R), First Electronic Growth Hormone ...  -  Jan 29, 2007
PR Newswire (press release),About Saizen(R) Saizen(R) (somatropin) is a recombinant human growth hormone and is therapeutically equivalent to the natural growth hormone produced by the

Merck-Serono launches electronic growth hormone injection device  -  Jan 30, 2007
In-PharmaTechnologist.com,Intended for use with the company's Saizen (somatropin (rDNA origin) for injection) therapy, it is the latest product in the firm's drive to develop

Merck launches electronic growth hormone injection device  -  Jan 30, 2007
ABCmoney.co.uk,...the launch of electronic growth hormone injection device easypod for administering the company's hormone deficiency therapy Saizen (somatropin).

Merck Serono launches growth hormone injection device  -  Jan 30, 2007
News-Medical.net,Merck Serono has announced the launch of a unique growth hormone injection device, easypod, for the once-daily administration of Saizen (somatropin),

Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status ...  -  Jan 31, 2007
Seeking Alpha,Easypod is an injection device for the once-daily administration of Saizen, a growth hormone. The device allows the doctor to set the dosage, and the device

Merck Serono Completes Patient Enrollment in CLARITY Phase III ...  -  Jan 16, 2007
Drug Newswire (press release),It has strong market positions in neurology, with Rebif(R), as well as in metabolism and growth, with Saizen(R), Serostim(R) and Zorbtive(TM).

Merck Serono is Launched  -  Jan 7, 2007
Yahoo! News (press release)It has strong market positions in neurology, with Rebif®, as well as in metabolism and growth, with Saizen®, Serostim® and Zorbtive(TM).

Merck KGaA Acquires Majority Shareholding in Serono SA  -  Jan 5, 2007
Genetic Engineering News (press release),The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and

Merck KGaA Acquires Majority Shareholding in Serono SA  -  Jan 5, 2007
Yahoo! News (press release)The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel(R )/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®.

ZymoGenetics and Serono Begin Phase 2 Clinical Trial With ...  -  Dec 19, 2006
PR Newswire (press release),The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R)

Merck KGaA: European Antitrust Authorities Clear Acquisition of Serono  -  Dec 17, 2006
Yahoo! News (press release)The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel ®/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®.

Halozyme Therapeutics Names William Fallon Vice President ...  09 Nov 2006
...logistics departments of two commercial bulk manufacturing facilities producing mammalian cell culture derived biopharmaceutical products (Saizen(R) and ... -PR Newswire (press release), Serono posts better-than-forecast Q3 results, driven by MS drug ...  Oct 19, 2006
Growth hormone Saizen sales were slightly down at 50.5 mln usd compared to 50.8 mln usd in the previous year, while HIV drug Serostim sales grew 9.5 pct to ... -Forbes, 24-Week Clear Study Results Confirm Sustained Efficacy and Safety ...  Oct 30, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... -PR Newswire UK (press release), Serono Delivers Strong Adjusted* Net Income of $183.5m in Third ...  Oct 18, 2006
...products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 11.5%, or 9.5% in local currencies to $21.9m (Q3 2005: $19.6m). Saizen(R) sales were ... -PR Newswire (press release), 24-Week Clear Study Results Confirm Sustained Efficacy And Safety ...  Oct 31, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, Zorbtive™ and Raptiva®. ... -PipelineReview.com (press release), Serono Delivers Strong Adjusted* Net Income of $183.5m in Third ...  Oct 18, 2006
...$19.6m). Saizen(R) sales were $50.5m (Q3 2005: $50.8m), while Serostim(R) sales grew 9.5% to $19.5m (Q3 2005: $17.8m). Sales of ... -MSN Money Serono and Newron Announce Global Development and ...  Oct 15, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... -Earthtimes.org Serono and Newron Announce Global Development and ...  Oct 15, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel(R )/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... -Yahoo! News (press release) Merck KGaA Agrees to Buy Serono for $13.3 Billion (Update6)  Sep 21, 2006
Ares- Serono began selling its first product based on biotechnology, Saizen, for growth hormone deficiency in children, in 1989. ... -Bloomberg

Merck KgaA to Acquire Serono  Sep 21, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel(R )/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... -Yahoo! News

Serono's Oral Cladribine for the Treatment of Multiple Sclerosis ...  Sep 21, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... -PharmaLive.com

Serono And Syntonix To Pursue The Development Of A Long-Acting ...  Sep 19, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, Zorbtive™ and Raptiva®. ... -PipelineReview.com

BioMarin and Serono Announce Data on Phenoptin in PKU to be ...  Sep 12, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... -PharmaLive.com

Serono Announces Initiation of the Reflex Trial to Evaluate New ...  -  12 Dec 2006
Drug Newswire (press release),The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ...

Serono Q2 net profit rises 8 pct, sales disappoint - UPDATE  Jul 27, 2006
Other major Serono products showed a mixed performance, with sales for growth drug Saizen up 0.4 pct to 53.8 mln, sales for dermatology drug Raptiva surging by ... -Forbes

Serono Announces Results From Pivotal Phase III Clinical Trial of ...  Aug 17, 2006
...lutropin alfa), Ovidrel Prefilled Syringe(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin) for injection], Saizen(R) [somatropin ... -PR Newswire

Serono Risk From Legal Uncertainty Eyed  Jul 27, 2006
...the US lawsuits on inappropriate sales and marketing practices which now cover most of Serono's product line including Rebif, Gonal-f, Saizen and Serostim adds ... -newratings.com

Serono Q2 profit rises  Jul 27, 2006
Products key to driving growth include Rebif, which saw its sales rise 10.9% for the quarter, to reach $361.6 million, as well as Gonal-f, Saizen and Raptiva ... -Pharmaceutical Business Review

Get the latest news direct to your desktop  Aug 18, 2006
...alfa), Ovidrel Prefilled Syringe® (choriogonadotropin alfa injection), Serostim® [somatropin (rDNA origin) for injection], Saizen® [somatropin (rDNA origin ... -PipelineReview.com

Serono Delivers Second Quarter EPS of $12.92, Up 25.2% on Adjusted ...  Jul 26, 2006
2005: $22.2m). Saizen® sales were $53.8m (Q2 2005: $53.6m), a growth of 7.6% over the first quarter of 2006. Serostim® sales were ... -Yahoo! News

Serono Delivers Second Quarter EPS of $12.92, Up 25.2% on Adjusted ...  Jul 26, 2006
...products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 6.9%, or 7.5% in local currencies to $23.8m (Q2 2005: $22.2m). Saizen(R) sales were $53.8 ... -PR Newswire

European Commission Approves Revision of Therapeutic Indication ...  Jul 9, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel® /Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... -Yahoo! News

European Commission Approves Revision of Therapeutic Indication ...  Jul 10, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... -PharmaLive.com



Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/ Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - Genetic Engineering News

Serono Announces New Appointments to its Executive Management ...  May 9, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - PharmaLive.com

Novartis Unit Gets Approval For Copycat of Biotech Drug  Apr 18, 2006
...obtained approval for the recombinant human growth hormone Omnitrope, a biosimilar, or generic version, of Pfizer Inc.'s Genotropin and Serono SA's Saizen. ... - Wall Street Journal (subscription)

Serono Delivers Strong First Quarter 2006 With Revenue Growth of ...  Apr 19, 2006
Saizen® sales increased by 4.4%, or 10.0% in local currencies, to $49.9m (Q1 2005: $47.8m). Saizen® continues to be differentiated using the innovative ... - Yahoo! News

Serono Delivers Strong First Quarter 2006 With Revenue Growth of ...  Apr 19, 2006
...sales of supporting products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 11.3%, or 16.6% in local currencies, to $22.6m. Saizen(R) sales ... - PR Newswire

Serono Announces New Appointments to its Executive Management ...  May 8, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel(R )/Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... - Yahoo! News

Phase III Trial Of Oral Cladribine, A Novel Investigational ...  May 5, 2006
Ovidrel PreFilled Syringe(R)/Ovitrelle(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin) for injection], Saizen(R) [somatropin ... - Medical News Today

Serono Shareholders Approve Resolutions at Annual General Meeting  Apr 25, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel® /Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... - Yahoo! News

Serono Shareholders Approve Resolutions at Annual General Meeting  Apr 25, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - PharmaLive.com





Serono Says Its Controlling Shareholder, Bertarelli Family ...  Apr 9, 2006
With its eight biotechnology products such as Rebif, Gonal-f, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive and Raptiva, Serono achieved worldwide ... - Trading Markets



Seronons 2005 Adjusted(i) EPS Increased by 34.6%  Feb 5, 2006
Saizen(R) sales increased by 13.4% (12.5% in local currencies) to $206.5m (2004: $182.1m) in 2005, and were up 2.1% (5.9% in local currencies) to $54.3m (2004 ... - MSN Money

Novartis' Omnitrope Has Serono Implications  Jan 30, 2006
Meanwhile, potential new competition from Omnitrope will be critical to Serono (SRA), which makes around 8% of overall sales off its growth hormone Saizen. ... - New Ratings

Dead kangaroos don’t bounce, do they?  Jan 14, 2006
...development. The company markets eight recombinant products – Rebif, Gonal-f, Saizen, Serostim, Ovidrel, Luveris, Zorbtive and Raptiva. ... - Business Online

Serono Shares Drop on Report It Didn't Get Offers (Update1)  Jan 24, 2006
...psoriasis medicine Raptiva, ovulation hormone Ovidrel, progesterone gel Crinone, ovulation control hormone Cetrotide and growth hormone Saizen, which together ... - Bloomberg

Serono Completes Second Phase III Trial of its Proprietary ...  Jan 8, 2006
The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel® /Ovitrelle®, Serostim®, Saizen®, Zorbtive(TM) and Raptiva®. ... - Yahoo! News

Serono Completes Second Phase III Trial of its Proprietary ...  Jan 8, 2006
The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R ... - PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional